# OGIVRI

NDC: 83257-003
Generic name: trastuzumab-dkst
Labeler / Manufacturer: Biocon Biologics Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20231001

FDA application: BLA761074

## Active ingredients

- TRASTUZUMAB: 420 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83257-003"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83257-003
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b6465b44-a6dd-f99c-d009-6851cf05169c